HeartFlow, Inc. is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product-an AI-driven, non-invasive cardiac test ...
as described by GS 126 May Apply. This position serves as the Division Maintenance Engineer. Responsibilities include management... Special Qualifications may require registration as a professional engineer by the North Carolina Board of Examiners...
Be a Part of Simulating Future Innovations and Ideas COMSOL is seeking an Applications Engineer to join its Pre-sales... your success in your role as an Applications Engineer will be other simulation engineers and software developers who occupy the top...
direction of the Program Cost Controls Lead, the Cost Controls Engineer is responsible for developing, maintaining... and requests. Support the Program Cost Controls Lead and Senior Cost Engineer in reviews and meetings. Reconciliation and edits...
Job Title: Associate Engineer, BioPharma Data Analytics - Hybrid (JP13532) Location: Thousand Oaks, CA Or Cambridge... an Associate Engineer for a consulting engagement with our direct client, a leading global biotechnology company...
The UK followed other European countries with spectacular firework displays, after New Zealand and Australia were the first to celebrate.
Continue Reading »
Rajasthan-based rubber-conveyor belt manufacturer, Eureka Conveyor Belting, received the BSE approval to raise funds through an SME IPO from the public markets, according to the official release. Continue Reading »
Wall Street Holiday: The US stock exchanges will remain closed on Wednesday, January 1, 2025, on account of New Year celebrations across the globe. Continue Reading »
Vikas Ecotech stock has risen by 9.51 per cent from its 52-week low of ₹3.05 per share. This penny stock is worth monitoring for investors. Continue Reading »
Expert view: Anirudh Garg of Invasset PMS predicts the Nifty 50 may drop below 22,000 in 2025 before recovering. He sees the index as fairly priced, with an 8-10% downward bias, despite a bullish outlook over the next two years. Continue Reading »